Literature DB >> 18268344

A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis.

Arnaud Couzinet1, Kaoru Tamura, Hui-Min Chen, Keishiro Nishimura, Zhichao Wang, Yasuyuki Morishita, Kazuyoshi Takeda, Hideo Yagita, Hideyuki Yanai, Tadatsugu Taniguchi, Tomohiko Tamura.   

Abstract

Apoptosis is a highly regulated process of cell suicide that occurs during development, host defense, and pathophysiology. The transcription factor IFN regulatory factor 5 (IRF5), known to be involved in the activation of innate immune responses, recently has been shown to be critical for DNA damage-induced apoptosis and tumor suppression. Here, we report on a cell-type-specific role of IRF5 in promoting apoptosis upon signaling through the death receptor Fas (CD95/APO-1/TNFRSF6). In particular, we show that mice deficient in the Irf5 gene are resistant to hepatic apoptosis and lethality in response to the in vivo administration of a Fas-activating monoclonal antibody, and that IRF5 is involved in a stage of Fas signaling that precedes the activation of caspase 8 and c-Jun N-terminal kinase (JNK). In addition to hepatocytes, IRF5 is also required for apoptosis in dendritic cells activated by hypomethylated CpG but not in thymocytes and embryonic fibroblasts in vitro. Thus, these findings reveal a cell-type-specific function for IRF5 in the complex regulatory mechanism of death-receptor-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268344      PMCID: PMC2268175          DOI: 10.1073/pnas.0712295105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release.

Authors:  J Whitfield; S J Neame; L Paquet; O Bernard; J Ham
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

Review 2.  Fas ligand-induced apoptosis.

Authors:  S Nagata
Journal:  Annu Rev Genet       Date:  1999       Impact factor: 16.830

3.  Apoptosis is promoted by the dsRNA-activated factor (DRAF1) during viral infection independent of the action of interferon or p53.

Authors:  B K Weaver; O Ando; K P Kumar; N C Reich
Journal:  FASEB J       Date:  2001-02       Impact factor: 5.191

4.  Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes.

Authors:  B J Barnes; P A Moore; P M Pitha
Journal:  J Biol Chem       Date:  2001-04-12       Impact factor: 5.157

5.  Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells.

Authors:  Y Matsuki; L Li; H-C Hsu; P A Yang; R Zheng; C K Edwards; I H Chaudry; H-G Zhang; J D Mountz
Journal:  Cell Death Differ       Date:  2002-06       Impact factor: 15.828

6.  BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons.

Authors:  C A Harris; E M Johnson
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

7.  An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes.

Authors:  Anne-Odile Hueber; Anne-Marie Bernard; Zoltan Herincs; Arnaud Couzinet; Hai-Tao He
Journal:  EMBO Rep       Date:  2002-01-29       Impact factor: 8.807

8.  Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53.

Authors:  Toshiki Mori; Yoshio Anazawa; Megumi Iiizumi; Seisuke Fukuda; Yusuke Nakamura; Hirofumi Arakawa
Journal:  Oncogene       Date:  2002-04-25       Impact factor: 9.867

9.  Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes.

Authors:  Betsy J Barnes; Merrill J Kellum; Ann E Field; Paula M Pitha
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.

Authors:  Peter B Stranges; Jessica Watson; Cristie J Cooper; Caroline-Morgane Choisy-Rossi; Austin C Stonebraker; Ryan A Beighton; Heather Hartig; John P Sundberg; Stein Servick; Gunnar Kaufmann; Pamela J Fink; Alexander V Chervonsky
Journal:  Immunity       Date:  2007-05       Impact factor: 31.745

View more
  37 in total

Review 1.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

Review 2.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

3.  Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.

Authors:  Yuan Xu; Pui Y Lee; Yi Li; Chao Liu; Haoyang Zhuang; Shuhong Han; Dina C Nacionales; Jason Weinstein; Clayton E Mathews; Lyle L Moldawer; Shi-Wu Li; Minoru Satoh; Li-Jun Yang; Westley H Reeves
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

4.  The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stability.

Authors:  Justyna Korczeniewska; Betsy J Barnes
Journal:  Mol Cell Biol       Date:  2012-12-28       Impact factor: 4.272

5.  Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.

Authors:  Kei Yasuda; Kerstin Nündel; Amanda A Watkins; Tania Dhawan; Ramon G Bonegio; Jessalyn M Ubellacker; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  Int Immunol       Date:  2013-01-04       Impact factor: 4.823

6.  IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Authors:  Christophe Richez; Kei Yasuda; Ramon G Bonegio; Amanda A Watkins; Tamar Aprahamian; Patricia Busto; Rocco J Richards; Chih Long Liu; Regina Cheung; Paul J Utz; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

7.  IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans.

Authors:  Fawaz Alzaid; Floriane Lagadec; Miguel Albuquerque; Raphaëlle Ballaire; Lucie Orliaguet; Isabelle Hainault; Corinne Blugeon; Sophie Lemoine; Agnès Lehuen; David G Saliba; Irina A Udalova; Valérie Paradis; Fabienne Foufelle; Nicolas Venteclef
Journal:  JCI Insight       Date:  2016-12-08

8.  Cell type-dependent proapoptotic role of Bcl2L12 revealed by a mutation concomitant with the disruption of the juxtaposed Irf3 gene.

Authors:  Akira Nakajima; Keishiro Nishimura; Yukana Nakaima; Tomohiko Oh; Shigeru Noguchi; Tadatsugu Taniguchi; Tomohiko Tamura
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-17       Impact factor: 11.205

9.  Functional analysis of a dominant negative mutation of interferon regulatory factor 5.

Authors:  Long Yang; Tiejun Zhao; Xiaoliu Shi; Peyman Nakhaei; Yunling Wang; Qiang Sun; John Hiscott; Rongtuan Lin
Journal:  PLoS One       Date:  2009-05-11       Impact factor: 3.240

10.  Development of monoclonal antibodies against human IRF-5 and their use in identifying the binding of IRF-5 to nuclear import proteins karyopherin-alpha1 and -beta1.

Authors:  Soo-In Yeon; Ju Ho Youn; Mi Hwa Lim; Hye Ja Lee; Young Mok Kim; Ji Eun Choi; Jae Myun Lee; Jeon-Soo Shin
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.